Periodontitis
Conditions
Keywords
Periodontitis, Non-surgical periodontal therapy, Re-evaluation
Brief summary
Oral hygiene quality is a key determinant of outcomes in both non-surgical and surgical periodontal therapy. Previous studies have demonstrated the negative impact of site-specific plaque accumulation on periodontal parameters. However, to the best of our knowledge, no studies have specifically investigated the correlation between plaque index and the percentage reduction in periodontal pocket depth, nor its association with other periodontal clinical parameters. The aim of this study is to evaluate the relationship between plaque index and the percentage reduction in periodontal pockets, as well as its association with key periodontal parameters. Following baseline data collection, patients will undergo non-surgical periodontal therapy in accordance with current guidelines. Clinical outcomes will be reassessed at 3, 6, 9, and 12 months post-treatment.
Interventions
Patients will receive non-surgical periodontal therapy, including professional supragingival (Step 1) and subgingival scaling and root planing (Step 2), according to current guidelines (Herrera et al., 2023). Oral hygiene instructions will be provided at baseline and reinforced at each follow-up visit. Clinical outcomes, including percentage of pocket depth reduction and plaque index (FMPS), will be recorded at 3, 6, 9, and 12 months post-treatment.
Sponsors
G. d'Annunzio University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
* Diagnosis of periodontitis according to current guidelines. * Age between 18 and 80 years.
Exclusion criteria
* Patients who have previously received periodontal treatment. * Patients currently on antibiotic therapy or who have taken antibiotics in the past 3 months. * Pregnant or breastfeeding women. * Presence of systemic diseases or use of medications in which periodontal treatment is contraindicated or could affect study outcomes (e.g., antihypertensives, antiepileptics, immunosuppressants).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of probing pocket depth reduction | Baseline, 3, 6 9 and 12 months | The primary outcome is the percentage reduction in probing pocket depth (PPD) at treated sites compared to baseline. PPD will be measured using a calibrated periodontal probe at each follow-up visit (3, 6, 9, and 12 months). |
Countries
Italy
Contacts
CONTACTMatteo Serroni, DDS
PRINCIPAL_INVESTIGATORMatteo Serroni
'G. D'annunzio' University of Chieti-Pescara
Outcome results
None listed